140 related articles for article (PubMed ID: 30724469)
1. Serine/arginine protein-specific kinase 2 promotes the development and progression of pancreatic cancer by downregulating Numb and p53.
Wang G; Sheng W; Shi X; Li X; Zhou J; Dong M
FEBS J; 2019 May; 286(9):1668-1682. PubMed ID: 30724469
[TBL] [Abstract][Full Text] [Related]
2. Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer.
Wang G; Sheng W; Tang J; Li X; Zhou J; Dong M
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31898732
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
4. Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.
Sheng W; Dong M; Chen C; Li Y; Liu Q; Dong Q
Oncotarget; 2017 Feb; 8(9):14359-14373. PubMed ID: 27092875
[TBL] [Abstract][Full Text] [Related]
5. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
Zhou L; Sheng W; Jia C; Shi X; Cao R; Wang G; Lin Y; Zhu F; Dong Q; Dong M
J Cell Mol Med; 2020 Sep; 24(18):10560-10572. PubMed ID: 32779876
[TBL] [Abstract][Full Text] [Related]
6. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Cell Tissue Res; 2013 Nov; 354(2):521-32. PubMed ID: 23881403
[TBL] [Abstract][Full Text] [Related]
7. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
[TBL] [Abstract][Full Text] [Related]
8. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing of the cell fate determinant Numb in hepatocellular carcinoma.
Lu Y; Xu W; Ji J; Feng D; Sourbier C; Yang Y; Qu J; Zeng Z; Wang C; Chang X; Chen Y; Mishra A; Xu M; Lee MJ; Lee S; Trepel J; Linehan WM; Wang X; Yang Y; Neckers L
Hepatology; 2015 Oct; 62(4):1122-31. PubMed ID: 26058814
[TBL] [Abstract][Full Text] [Related]
10. RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells.
Yu C; Zhang X; Sun G; Guo X; Li H; You Y; Jacobs JL; Gardner K; Yuan D; Xu Z; Du Q; Dai C; Qian Z; Jiang K; Zhu Y; Li QQ; Miao Y
J Cell Mol Med; 2008 Dec; 12(6A):2334-49. PubMed ID: 18266952
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.
Xu D; Cobb MG; Gavilano L; Witherspoon SM; Williams D; White CD; Taverna P; Bednarski BK; Kim HJ; Baldwin AS; Baines AT
Cancer Biol Ther; 2013 Jun; 14(6):492-501. PubMed ID: 23760491
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of serine/threonine-protein kinase-1 in pancreatic cancer tissue: Serine/threonine-protein kinase-1 knockdown increases the chemosensitivity of pancreatic cancer cells.
Wang Q; Xu D; Han C; Tu M; Du Q; Zhang J; Zhu Y; Xu L
Mol Med Rep; 2015 Jul; 12(1):475-81. PubMed ID: 25760059
[TBL] [Abstract][Full Text] [Related]
14. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
Zhuo YJ; Liu ZZ; Wan S; Cai ZD; Xie JJ; Cai ZD; Song SD; Wan YP; Hua W; Zhong W; Wu CL
Biomed Pharmacother; 2018 Jun; 102():531-538. PubMed ID: 29587239
[TBL] [Abstract][Full Text] [Related]
16. Plk1 phosphorylation of Numb leads to impaired DNA damage response.
Shao C; Chien SJ; Farah E; Li Z; Ahmad N; Liu X
Oncogene; 2018 Feb; 37(6):810-820. PubMed ID: 29059161
[TBL] [Abstract][Full Text] [Related]
17. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
Liu J; Ma J; Wu Z; Li W; Zhang D; Han L; Wang F; Reindl KM; Wu E; Ma Q
BMC Cancer; 2014 Sep; 14():686. PubMed ID: 25240403
[TBL] [Abstract][Full Text] [Related]
18. NUMB controls p53 tumour suppressor activity.
Colaluca IN; Tosoni D; Nuciforo P; Senic-Matuglia F; Galimberti V; Viale G; Pece S; Di Fiore PP
Nature; 2008 Jan; 451(7174):76-80. PubMed ID: 18172499
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of SRPK2 promotes cell cycle arrest though E2F1 in non-small cell lung cancer.
Li X; Yang S; Zhang M; Xie S; Xie Z
Eur J Histochem; 2019 Dec; 63(4):. PubMed ID: 31833327
[TBL] [Abstract][Full Text] [Related]
20. HES 1 is essential for chemoresistance induced by stellate cells and is associated with poor prognosis in pancreatic cancer.
Cao F; Li J; Sun H; Liu S; Cui Y; Li F
Oncol Rep; 2015 Apr; 33(4):1883-9. PubMed ID: 25672829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]